- FDA reiterates warning of muscle injury risk when heart drugs combined
- In Brief: PreMD Inc.
- FDA places partial clinical hold on Celgene, MethylGene's cancer drug trials
- FDA reports new cases of pancreatitis seen with Byetta
- Santhera Pharmaceuticals' investigational congenital muscular dystrophy drug receives orphan drug designation
- Eight-week nicotine replacement therapy program improves quit rates compared with a two-week program, study shows
- Certain Medicare beneficiary subgroups failed to fill prescriptions before Part D implementation, new data show
- In Brief: California
- Concomitant asthma, COPD versus either disease alone linked with higher burden, data reveal
- In Brief: Illinois Gov. Rod Blagojevich
Home :: Cardiology :: Cardiology Conferences
ACC's 57th Annual Scientific Session
March 29 - April 1 2008 Chicago, IL- Different drugs used to reach cholesterol goal
- Use of prehospital ECGs reduces time to reperfusion, findings show
- Experts discuss ENHANCE trial data, implications for clinical practice
- Door-to-needle, door-to-balloon times have decreased since 1990s
- Celecoxib increases cardiovascular risk in dose-, regimen-related fashion
- CARISMA researchers use ILR to document arrhythmias in post-MI patients with low ejection fraction, identify high-degree AV block as independent predictor of cardiac death
- Rosuvastatin yields regression in coronary atherosclerosis
- Use of prehospital ECGs reduces time to reperfusion, findings show
- Experts discuss ENHANCE trial data, implications for clinical practice
- STRADIVARIUS trial fails to show effect of rimonabant in primary IVUS endpoint, but secondary endpoint data suggest drug might reduce atherosclerosis progression
- Radiotherapy, chemotherapy increase risks of second malignancy, cardiovascular disease similar to smoking in patients with testicular cancer, researchers report
- Lipid-modifying drugs may decrease all-cause, cardiovascular-specific mortality in patients on peritoneal dialysis, study data suggest
- Hypertension common as well as poorly controlled in patients with cardiovascular comorbidities
- Experts discuss ENHANCE trial data, implications for clinical practice
- Use of prehospital ECGs reduces time to reperfusion, findings show
All material on this Web site is protected by copyright. Copyright © 1994-2008 by VerusMed, a ConnectivHealth company. This Web site may also contain material copyrighted by third parties.